Resveratrol inhibits the secretion of vascular endothelial growth factor and subsequent proliferation in human leukemia U937 cells

Abstract

This study examined the effect of resveratrol on the secretion of vascular endothelial growth factor (VEGF) and subsequent proliferation of human leukemia U937 cells, and explored the mechanisms involved. Human leukemia U937 cells were treated with resveratrol of different concentrations (12.5–200 μmol/L) for different time lengths (12–48 h). The proliferation of the U937 leukemic cells was determined by MTT assay. Apoptosis was observed by Annexin-V-FIFC/PI double staining and flow cytometry (FCM). Cells cycle was analyzed by PI staining and FCM. The content of VEGF was determined by ELISA. Human umbibical vein endothelial cells were examined for vasoformation in vitro after exposures to resveratrol of various concetrations. The results showed that resveratrol inhibited the proliferation of U937 leukemia cells in a dose-and time-dependent manner. Resveratrol induced apoptosis and S-phase cell cycle arrest in human leukemic U937 cells. Resveratrol inhibited the secretion of VEGF in U937 cells. Resveratrol inhibited the vasoformation of human vein endothelial cells in a dose-dependent manner. It was concluded that resveratrol could down-regulate the secretion of VEGF, induce apoptosis and suppress the proliferation of U937 cells.

Keywords

resveratrol / vascular endothelial growth factor / cell proliferation / U937 leukemia cells

References

[1] HainR., BieselerB., KindlH., et al.. Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol. Plant Mol Biol, 1990, 15: 325-335

[2] CorderR., DouthwaiteJ. A., LeesD. M., et al.. Endothelin-1 synthesis reduced by red wine. Nature, 2001, 414: 853-854

[3] JangM., CaiL., UdeaniG. O., et al.. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 1997, 275(10): 218-220

[4] AggarwalB. B., BhardwajA., AggarwalR. S., et al.. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res, 2004, 24: 2783-2840

[5] EstrovZ., ShishodiaS., FaderlS., et al.. Resveratrol blocks interleukin-1 {beta}-induced activation of the nuclear transcription factor NF-{kappa}B, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood, 2003, 102(3): 987-995

[6] BhardwajA., SethiG., Vadhan-RajS., et al.. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-{kappa}B-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood, 2007, 109(6): 2293-2302

[7] JoeA. K., LiuH., SuzuiM., et al.. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res, 2002, 8: 893-903

[8] ClementM. V., HirparaJ. L., ChawdhuryS. H., et al.. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood, 1998, 92: 996-1002

[9] FolkmanJ.. Angiogenesis and apoptosis. Semin Cancer Biol, 2003, 13: 159-167

[10] PadróT., RuizS., BiekerR., et al.. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood, 2000, 95: 2637-2644

[11] FragosoR., PereiraT., WuY., et al.. VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease. Blood, 2006, 107: 1608-1616

[12] LinM. T., YenM. L., LinC. Y., et al.. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Sre-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol, 2003, 64: 1029-1036

[13] SaijonmaaO., NymanT., KosonenR., et al.. Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor. Am J Physiol Heart Circ Physiol, 2001, 280: H885-H891

[14] GehmB. D., McAndrewsJ. M., ChienP. Y., et al.. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist of the estrogen receptor. Proc Natl Acad Sci USA, 1997, 94: 14138-14143

[15] RodrigueC. M., ArousN., BachirD., et al.. Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation. Br J Haematol, 2001, 113: 500-507

[16] FujitaM., HayashiI., YamashinaS., et al.. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis, 2005, 26(2): 271-279

[17] DiasS., ChoyM., AlitaloK., et al.. VEGF(165) promotes survival of leukemic cells by Hsp90 mediated induction of Bcl-2 expression and apoptosis inhibition. Blood, 2002, 99(6): 2532-2540

[18] RodgersK. E., XiongS., SteerR., et al.. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells, 2000, 18(4): 287-294

[19] SatohC., FukudaN., HuW. Y., et al.. Role of endogenous angiotensin in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol, 2001, 37(1): 108-118

[20] SaijonmaaO., NymanT., KosonenR., et al.. Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor. Am J Physiol Heart Circ Physiol, 2001, 280(2): H885-H891